In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis

Agertt, Vanessa Albertina; Bonez, Pauline Cordenonsi; Mizdal, Caren Rigon; Rossi, Grazielle Guidolin; Flores, Vanessa da Costa; Campos, Marli Matiko Anraku de

doi:10.1590/s1984-82502016000300022

Cited by 1 publication

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As there is scientific evidence proving the benefits to the patient's health when a fixeddose combination (FDC) dosage form is used, this becomes the main aim to improve TB treatment in pediatrics [9][10][11]. The best option seems to be the development of orodispersible tablets, which disintegrates inside the mouth.…”

Section: Introductionmentioning

confidence: 99%

Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics

Suárez-González

Santoveña

Soriano

et al. 2020

Drug Development and Industrial Pharmacy

View full text Add to dashboard Cite

Objective: Develop a child-friendly Fixed Dose Combination (FDC) water-dispersible tablet for Tuberculosis (TB) treatment, with 50, 150 and 75 mg of isoniazid (INH), pyrazinamide (PZA) and rifampicin (RFP) respectively. This new formulation must contain the lowest possible number of excipients, all accepted for pediatrics, and fulfill all the pharmacopoeia requirements for this type of tablet (friability, disintegration time, fineness of dispersion and content uniformity).Significance: TB is an infectious disease which caused the death of 233,000 children in 2017. At present there is no adequate market dosage form available for children. There is, however, one in a prequalification phase by the World Health Organization but its composition contains some excipients which may not be suitable for pediatrics.Therefore, this new formulation would cover this therapeutic gap.Methods: A factorial design, based on 3 quantitative factors (compression force and concentration of AcDiSol® and Explosol®) at three levels each, was performed to elucidate their influence over disintegration time and friability. In addition, the influence of the press speed on disintegration time, friability, tensile strength, fineness of dispersion and content uniformity over the target tablet was tested. A stability test was done following ICH guideline for accelerated conditions.Results: A water-dispersible tablet was developed according to international recommendations in terms of excipients for pediatrics and meeting Ph. Eur. requirements.In addition, its production has been optimized to be elaborated at maximum eccentric press speed but maintaining quality requirements.Conclusion: A high-quality child-friendly FDC water-dispersible tablet was developed improving the treatment of TB in pediatric.

show abstract

Section: Introductionmentioning

confidence: 99%